These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9825251)

  • 1. [The impact of the central serotonin system on alcoholism and therapeutic consequences].
    Peter H; Bandelow B; Krausz M
    Fortschr Neurol Psychiatr; 1998 Oct; 66(10):459-65. PubMed ID: 9825251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the serotonergic system in the neurobiology of alcoholism: implications for treatment.
    Johnson BA
    CNS Drugs; 2004; 18(15):1105-18. PubMed ID: 15581381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin's Complex Role in Alcoholism: Implications for Treatment and Future Research.
    Marcinkiewcz CA; Lowery-Gionta EG; Kash TL
    Alcohol Clin Exp Res; 2016 Jun; 40(6):1192-201. PubMed ID: 27161942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sertraline and cognitive behavioral therapy for depressed alcoholics: results of a placebo-controlled trial.
    Moak DH; Anton RF; Latham PK; Voronin KE; Waid RL; Durazo-Arvizu R
    J Clin Psychopharmacol; 2003 Dec; 23(6):553-62. PubMed ID: 14624185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medications acting on the serotonergic system for the treatment of alcohol dependent patients.
    Kenna GA
    Curr Pharm Des; 2010; 16(19):2126-35. PubMed ID: 20482508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of selective serotonin reuptake inhibitors in treating alcoholic subtypes.
    Pettinati HM
    J Clin Psychiatry; 2001; 62 Suppl 20():26-31. PubMed ID: 11584872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy in alcoholism treatment: integrating and understanding the use of serotonin reuptake inhibitors.
    George FR
    Alcohol Alcohol Suppl; 1994; 2():537-43. PubMed ID: 8974380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of serotonin (5-hydroxytryptamine) reuptake inhibitors in the treatment of alcoholism.
    Lejoyeux M
    Alcohol Alcohol; 1996 Mar; 31 Suppl 1():69-75. PubMed ID: 8737004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin-altering medications and desire, consumption and effects of alcohol-treatment implications.
    Naranjo CA; Bremner KE
    EXS; 1994; 71():209-19. PubMed ID: 8032152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of fluoxetine at antidepressant doses on short-term outcome of detoxified alcoholics.
    Janiri L; Gobbi G; Mannelli P; Pozzi G; Serretti A; Tempesta E
    Int Clin Psychopharmacol; 1996 Jun; 11(2):109-17. PubMed ID: 8803648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of serotonin (5-hydroxytryptamine) reuptake inhibitors in the treatment of alcoholism.
    Lejoyeux M
    Alcohol Alcohol Suppl; 1996 Mar; 31(1):69-75. PubMed ID: 9845041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults.
    Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
    Cochrane Database Syst Rev; 2015 Apr; 4(4):CD002919. PubMed ID: 25829028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacology of serotonin-altering medications for decreasing alcohol consumption.
    Naranjo CA; Bremner KE
    Alcohol Alcohol Suppl; 1993; 2():221-9. PubMed ID: 7748304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of selective serotonin reuptake inhibitors in reducing alcohol consumption.
    Naranjo CA; Knoke DM
    J Clin Psychiatry; 2001; 62 Suppl 20():18-25. PubMed ID: 11584871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poorer Drinking Outcomes with Citalopram Treatment for Alcohol Dependence: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Charney DA; Heath LM; Zikos E; Palacios-Boix J; Gill KJ
    Alcohol Clin Exp Res; 2015 Sep; 39(9):1756-65. PubMed ID: 26208048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of serotonergic agents as treatments for alcoholism.
    Johnson BA
    Drugs Today (Barc); 2003 Sep; 39(9):665-72. PubMed ID: 14586482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of the selective serotonin-reuptake inhibitors fluoxetine, paroxetine, citalopram and fluvoxamine in alcohol-preferring cAA rats.
    Maurel S; De Vry J; Schreiber R
    Alcohol; 1999 Apr; 17(3):195-201. PubMed ID: 10231167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of fluvoxamine and citalopram in maintaining abstinence in a sample of Italian detoxified alcoholics.
    Angelone SM; Bellini L; Di Bella D; Catalano M
    Alcohol Alcohol; 1998; 33(2):151-6. PubMed ID: 9566477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comorbid alcoholism and depression: treatment issues.
    Thase ME; Salloum IM; Cornelius JD
    J Clin Psychiatry; 2001; 62 Suppl 20():32-41. PubMed ID: 11584873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonergic agents and alcoholism treatment: rebirth of the subtype concept--an hypothesis.
    Johnson BA
    Alcohol Clin Exp Res; 2000 Oct; 24(10):1597-601. PubMed ID: 11045870
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.